158 related articles for article (PubMed ID: 37660388)
1. The role of pneumococcal vaccination in reducing cardiovascular risk in cardiac patients: Expert opinion of the Prevention Committee of the Polish Cardiac Society supported by the Polish Vaccinology Society.
Mamcarz A; Wełnicki M; Drożdż J; Grabowski M; Jankowski P; Kuchar E; Leszek P; Mitkowski P; Wysocki J
Kardiol Pol; 2023; 81(10):1038-1046. PubMed ID: 37660388
[TBL] [Abstract][Full Text] [Related]
2. [Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].
Albrecht P; Antczak A; Hryniewicz W; Skoczyńska A; Radzikowski A; Kedziora-Kornatowska K; Bernatowska E; Stompór T; Grodzicki T; Gyrczuk E; Imiela J; Jedrzejczak W; Windak A
Pol Merkur Lekarski; 2014 Feb; 36(212):79-87. PubMed ID: 24720101
[TBL] [Abstract][Full Text] [Related]
3. Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pneumococcal non-typeable
Bhavsar A; Zaryczański J; Wasilewska A; Saragoussi D; Devadiga R; Colby C; Bahar E; Wysocki J
Hum Vaccin Immunother; 2022 Nov; 18(6):2128566. PubMed ID: 36239615
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.
Vila-Corcoles A; Ochoa-Gondar O
Expert Rev Vaccines; 2012 Feb; 11(2):221-36. PubMed ID: 22309670
[TBL] [Abstract][Full Text] [Related]
5. Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia.
van Werkhoven CH; Huijts SM
Clin Chest Med; 2018 Dec; 39(4):733-752. PubMed ID: 30390745
[TBL] [Abstract][Full Text] [Related]
6. [Impact of co-infection of streptococcus pneumoniae and pneumococcal vaccination on the clinical outcomes of coronavirus disease 19].
Bai YH; Zhang Z; Li SP
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 May; 56(5):659-667. PubMed ID: 35644983
[TBL] [Abstract][Full Text] [Related]
7. The cost effectiveness of pneumococcal vaccination strategies.
Gable CB; Botteman M; Savage G; Joy K
Pharmacoeconomics; 1997 Aug; 12(2 Pt 1):161-74. PubMed ID: 10169668
[TBL] [Abstract][Full Text] [Related]
8. A pediatric case series of invasive pneumococcal disease caused by
Cura Yayla BC; Bedir Demirdag T; Akkuzu E; Kara N; Tezer H; Tapisiz A
Hum Vaccin Immunother; 2023 Aug; 19(2):2219186. PubMed ID: 37334472
[No Abstract] [Full Text] [Related]
9. [Pneumococcal vaccine recommendations in chronic respiratory diseases].
Casas Maldonado F; Alfageme Michavila I; Barchilón Cohen VS; Peis Redondo JI; Vargas Ortega DA
Semergen; 2014 Sep; 40(6):313-25. PubMed ID: 25107494
[TBL] [Abstract][Full Text] [Related]
10. Adult pneumococcal vaccination guideline. SAMA-SA Pulmonology Society Working Group.
S Afr Med J; 1999 Nov; 89(11 Suppl):1222-30. PubMed ID: 10599303
[TBL] [Abstract][Full Text] [Related]
11. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
Baldo V; Cocchio S; Gallo T; Furlan P; Romor P; Bertoncello C; Buja A; Baldovin T
PLoS One; 2016; 11(11):e0166637. PubMed ID: 27846277
[TBL] [Abstract][Full Text] [Related]
12. [Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland].
Jahnz-Rózyk K
Pol Merkur Lekarski; 2010 Jul; 29(169):37-40. PubMed ID: 20712246
[TBL] [Abstract][Full Text] [Related]
13. The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion.
Rashid H; Abdul Muttalif AR; Mohamed Dahlan ZB; Djauzi S; Iqbal Z; Karim HM; Naeem SM; Tantawichien T; Zotomayor R; Patil S; Schmitt HJ
Travel Med Infect Dis; 2013; 11(5):288-94. PubMed ID: 23810307
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age.
Isturiz RE; Hall-Murray C; McLaughlin JM; Snow V; Schmoele-Thoma B; Webber C; Thompson A; Scott DA
Expert Rev Vaccines; 2018 Jan; 17(1):45-55. PubMed ID: 29183235
[TBL] [Abstract][Full Text] [Related]
15. The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy.
Anderson R; Feldman C
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446214
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal disease.
Kopp A; Mangin O; Gantzer L; Lekens B; Simoneau G; Ravelomanantsoa M; Evans J; Bergmann JF; Sellier P
Hum Vaccin Immunother; 2021 Jan; 17(1):162-169. PubMed ID: 32429734
[No Abstract] [Full Text] [Related]
17. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
Ingels HA
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of pneumococcal infections in the elderly.
Butler JC; Schuchat A
Drugs Aging; 1999; 15 Suppl 1():11-9. PubMed ID: 10690791
[TBL] [Abstract][Full Text] [Related]
19. [Expert consensus on immunization for prevention of pneumococcal disease in China (2017)].
;
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):111-138. PubMed ID: 29495194
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal disease manifestation in children before and after vaccination: what's new?
Andrade AL; Toscano CM; Minamisava R; Costa PS; Andrade JG
Vaccine; 2011 Sep; 29 Suppl 3():C2-14. PubMed ID: 21896349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
